Real-World Evidence for Medicare Drug Price Negotiations

Colleen Carey; Matthew L Maciejewski

doi:10.1001/jama.2025.21498

Real-World Evidence for Medicare Drug Price Negotiations

JAMA. 2026 Jan 6;335(1):15-16. doi: 10.1001/jama.2025.21498.

Authors

Colleen Carey¹, Matthew L Maciejewski^{2

3}

Affiliations

¹ Brooks School of Public Policy and Department of Economics, Cornell University, Ithaca, New York.
² Department of Population Health Sciences and Duke-Margolis Center for Health Policy, Duke University, Durham, North Carolina.
³ Durham Center of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Medical Center, Durham, North Carolina.

PMID: 41343172
DOI: 10.1001/jama.2025.21498

No abstract available

Plain language summary

This Viewpoint discusses how real-world evidence studies could help the US Centers for Medicare & Medicaid Services align spending with value in their drug price negotiations.